Naifa Busaidy is Tenured Associate Professor at University of Texas–MD Anderson Cancer Center. Clinical & research expertise/interests are primarily focused-driven to improve outcomes in aggressive thyroid carcinomas patients.
Busaidy attended Baylor College of Medicine medicalschool, residency and fellowship with researchfellowship-UTMDAnderson to advance her clinical/research knowledge in Endocrine Tumors. She joined the UTMDACC faculty where she serves on committees & directs thyroid nodule clinic.
She serves as PI/Co-PI of NCI and industry trials with aims to identify molecular mechanisms of disease progression and targets for improving response to therapy.
She serves on NCCN Thyroid Cancer Guidelines, NCI’s PI3K/mTOR taskforce and advisory boards/consultant for oncology groups/industry to shape the treatment spectrum of thyroid cancer.
She is an ITOG member, where she serves on the board, ATA, where she served program, research grant and awards committees, AACE(fellow), Endocrine Society. She has published extensively on thyroid cancer and Endocrine effects of cancer therapy.